Breckenridge Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty-eight approved drugs.
There are five tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
US Patents: | 0 |
Tradenames: | 45 |
Ingredients: | 45 |
NDAs: | 48 |
Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | MEGESTROL ACETATE | megestrol acetate | SUSPENSION;ORAL | 204688-001 | Dec 1, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Breckenridge | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 203481-001 | Jul 3, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Breckenridge Pharm | TERBINAFINE HYDROCHLORIDE | terbinafine hydrochloride | TABLET;ORAL | 077714-001 | Jun 4, 2010 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Breckenridge | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 091170-001 | Mar 4, 2013 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Breckenridge | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 203481-002 | Jul 3, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Breckenridge | POMALIDOMIDE | pomalidomide | CAPSULE;ORAL | 210111-004 | Oct 30, 2020 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Breckenridge | EXEMESTANE | exemestane | TABLET;ORAL | 211031-001 | Feb 21, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.